Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl S Peggs

Showing results (1-10 of 155) with videos related to

Pageof 16
Sort By:
British Journal of Haematology|July 18, 2015
Recent advances in antibody-based therapies for Hodgkin LymphomaKarl S Peggs
Expert Review of Anti-Infective Therapy|October 16, 2004
Cytomegalovirus following stem cell transplantation: from pharmacologic to immunologic therapyKarl S Peggs
Leukemia & Lymphoma|September 14, 2004
Immune reconstitution following stem cell transplantationKarl S Peggs
Expert Opinion on Biological Therapy|May 22, 2009
Adoptive T cell immunotherapy for cytomegalovirusKarl S Peggs
Expert Review of Anticancer Therapy|November 5, 2011
Chimeric antigen receptors: a costimulatory boost promotes immunological memory to B-cell malignanciesKarl S Peggs
Leukemia & Lymphoma|June 7, 2006
Improving cellular therapies in Epstein - Barr virus-associated Hodgkin's lymphoma: shifting the equilibrium between effectors and regulatorsKarl S Peggs
Blood|September 14, 2013
Attack of the T-cell clonesKarl S Peggs
Blood|August 1, 2024
Human herpesvirus 6 and CAR T-cell toxicityKarl S Peggs
Blood Advances|April 12, 2018
Should all patients with Hodgkin lymphoma who relapse after autologous SCT be considered for allogeneic SCT?Karl S Peggs
Expert Opinion on Biological Therapy|January 29, 2011
Donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantationClaire Roddie, Karl S Peggs
Pageof 16

Showing results (1-10 of 155) with videos related to

Sort By:
Pageof 16
British Journal of Haematology|July 18, 2015
Recent advances in antibody-based therapies for Hodgkin LymphomaKarl S Peggs
Expert Review of Anti-Infective Therapy|October 16, 2004
Cytomegalovirus following stem cell transplantation: from pharmacologic to immunologic therapyKarl S Peggs
Leukemia & Lymphoma|September 14, 2004
Immune reconstitution following stem cell transplantationKarl S Peggs
Expert Opinion on Biological Therapy|May 22, 2009
Adoptive T cell immunotherapy for cytomegalovirusKarl S Peggs
Expert Review of Anticancer Therapy|November 5, 2011
Chimeric antigen receptors: a costimulatory boost promotes immunological memory to B-cell malignanciesKarl S Peggs
Leukemia & Lymphoma|June 7, 2006
Improving cellular therapies in Epstein - Barr virus-associated Hodgkin's lymphoma: shifting the equilibrium between effectors and regulatorsKarl S Peggs
Blood|September 14, 2013
Attack of the T-cell clonesKarl S Peggs
Blood|August 1, 2024
Human herpesvirus 6 and CAR T-cell toxicityKarl S Peggs
Blood Advances|April 12, 2018
Should all patients with Hodgkin lymphoma who relapse after autologous SCT be considered for allogeneic SCT?Karl S Peggs
Expert Opinion on Biological Therapy|January 29, 2011
Donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantationClaire Roddie, Karl S Peggs
Pageof 16